Experience with the use of perilesional and intralesional recombinant human epidermal growth factor (nepidermin) in the treatment of patients with chronic venous ulcers

Cacua Sánchez, María TeresaGiraldo, Luis Fernando2020-03-252020-03-2520191553-8036https://hdl.handle.net/20.500.12495/2107application/pdfengExperience with the use of perilesional and intralesional recombinant human epidermal growth factor (nepidermin) in the treatment of patients with chronic venous ulcersarticleFactor de crecimiento epidérmicoÚlcera varicosa -- TratamientoFamilia de proteínas EGFNepiderminRecombinant human epidermal growth factorVenous ulcersinstname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coExperience with the use of perilesional and intralesional recombinant human epidermal growth factor (nepidermin) in the treatment of patients with chronic venous ulcersAcceso cerradoinfo:eu-repo/semantics/openAccesshttps://purl.org/coar/access_right/c_abf4632019